Pharmacogenetics (PGX) or personalized medicine provides data that allows physicians to personalize patients’ medication(s) based on each patient’s genetic profile. An estimated 80 percent of pharmaceuticals are designed to metabolize through the “super family” Cytochrome P450 liver enzymes. PrevMed’s laboratory partners specialize in identifying patients’ metabolizer status by analyzing the rate at which patients metabolize drugs through various pathways in the P450 super family by utilizing a simple cheek swab performed in a physician’s office. The information provided allows a physician to choose the right medication and the right dose for the patient. By genotyping for metabolizer status, physicians are contributing to the reduction of adverse drug events (ADE) which is currently the sixth leading cause of death in the United States affecting 106,000 people, and costing the healthcare system an estimated $136 billion to treat annually. PrevMed works with multiple lab partners to provide the best choice for physicians and patients for coverage considerations, and is committed to providing the highest standard of precision prescribing with the use of genotyping. Final results are reported in about seven to ten days in a very “easy to use” report accessed online.
- Helps find the right medicine at the right dose at the right time.
- Aids in the prevention of adverse drug reactions
- Tailor treatment based on the individual
- Removes the guess work when prescribing medications
- Provides a deeper insight to the patients you are treating
- We also have FDA approved PGx kits